0001209191-20-016786.txt : 20200305
0001209191-20-016786.hdr.sgml : 20200305
20200305193207
ACCESSION NUMBER: 0001209191-20-016786
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200304
FILED AS OF DATE: 20200305
DATE AS OF CHANGE: 20200305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manning Daniel E.
CENTRAL INDEX KEY: 0001741456
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38525
FILM NUMBER: 20692236
MAIL ADDRESS:
STREET 1: 255 SOUTH KING ST., SUITE 1800
CITY: SEATTLE
STATE: WA
ZIP: 98104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVALARA, INC.
CENTRAL INDEX KEY: 0001348036
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 911995935
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 255 S. KING ST.
STREET 2: SUITE 1800
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: (206) 826-4900
MAIL ADDRESS:
STREET 1: 255 S. KING ST.
STREET 2: SUITE 1800
CITY: SEATTLE
STATE: WA
ZIP: 98104
FORMER COMPANY:
FORMER CONFORMED NAME: AVALARA INC
DATE OF NAME CHANGE: 20051227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-04
0
0001348036
AVALARA, INC.
AVLR
0001741456
Manning Daniel E.
255 SOUTH KING ST.
SUITE 1800
SEATTLE
WA
98104
0
1
0
0
Chief Accounting Officer
Common Stock
2020-03-04
4
M
0
6248
13.76
A
13249
D
Common Stock
2020-03-04
4
M
0
6701
16.60
A
19950
D
Common Stock
2020-03-04
4
S
0
9985
83.29
D
9965
D
Common Stock
2020-03-04
4
S
0
2964
84.09
D
7001
D
Stock Option (right to buy)
13.76
2020-03-04
4
M
0
6248
0.00
D
2026-12-13
Common Stock
6248
4692
D
Stock Option (right to buy)
16.60
2020-03-04
4
M
0
6701
0.00
D
2028-01-23
Common Stock
6701
12285
D
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.95 to $83.88 inclusive. Upon request by Avalara, Inc., any security holder thereof, or the staff of the Securities and Exchange Commission, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.01 to $84.15, inclusive.
The option vested and became exercisable as to 25% of the total shares on November 30, 2017, and 1/48th of the total shares vest and become exercisable monthly thereafter such that the option is fully vested and exercisable on November 30, 2020.
The option vested and became exercisable as to 25% of the total shares on January 1, 2019, and 1/48th of the total shares vest and become exercisable monthly thereafter such that the option is fully vested and exercisable on January 1, 2022.
/s/ Alesia L. Pinney, Attorney-in-Fact
2020-03-05